Records containing: Hepatic Failure
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-09Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure
-
CLINICAL_TRIALS study record update · 2026-03-24Pyrophosphate Homeostasis and Hepatic Expression of ABCC6. Pilot Study in Liver Transplantation
-
CLINICAL_TRIALS study record update · 2025-06-04Perioperative Use of Amino Acids in Recipients of Orthotopic Liver Transplantation as a Renal Protective Factor
-
CLINICAL_TRIALS study record update · 2024-06-20A Phase 1, Open-label, Single-dose, Parallel-group Study to Evaluate the Systemic Pharmacokinetics of Icenticaftor in Participants With Mild, Moderate, or Severe Hepatic Impairment Compared to Matched Healthy Control Participants
-
CLINICAL_TRIALS study record update · 2024-01-16Thyoid Dysfucntion; Does it Affect the Short Term Outcome of Heptic Failure Patiens ?
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-11-03The Role of Skin Microbiota in Patients With Hepatic or Renal Pruritus
-
CLINICAL_TRIALS study record update · 2020-08-27A Phase 1, Open-Label, Parallel Group, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986231 in Participants With Varying Degrees of Hepatic Impairment
-
CLINICAL_TRIALS study record update · 2018-06-18Study of High - Flux Plasma Diafiltration Based on Plasma - Saved Mode in the Treatment of Patients With Hepatic Failure
-
CLINICAL_TRIALS study record update · 2016-10-24Pharmacokinetics of Buprenorphine and Naloxone in Subjects With Mild to Severe Hepatic Impairment (Child-Pugh Classes, A, B, and C), in HCV-Seropositive Subjects, and in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2016-01-15A Feasibility Study to Determine an Adequate Dose of ICG for the Liver Function Assessment System in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2016-01-15A Pivotal, Within Subject, Comparison of the LFT™ Dye Monitor System to the Indocyanine Green Dye (ICG) Serial Blood Plasma Disappearance Rate in Patients With Impaired and Non-Impaired Hepatic Function
-
CLINICAL_TRIALS study record update · 2009-09-16A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function